Autorenfreundlich Bücher kaufen?!
Beschreibung
A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.
Details
| Verlag | Springer International Publishing |
| Ersterscheinung | 23. Januar 2019 |
| Maße | 23.5 cm x 15.5 cm |
| Gewicht | 629 Gramm |
| Format | Hardcover |
| ISBN-13 | 9783030105068 |
| Auflage | 1st ed. 2018 |
| Seiten | 297 |
Schlagwörter
Herstellerinformationen
Bekannt durch
